tiprankstipranks
Trending News
More News >
MEI Pharma (MEIP)
NASDAQ:MEIP
US Market
Advertisement

MEI Pharma (MEIP) Technical Analysis

Compare
1,018 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
MEI Pharma’s (MEIP) Moving Averages Convergence Divergence (MACD) indicator is 1.07, suggesting MEI Pharma is a Sell.
MEI Pharma’s (MEIP) 20-Day exponential moving average is 4.28, while MEI Pharma’s (MEIP) share price is $6.6, making it a Buy.
MEI Pharma’s (MEIP) 50-Day exponential moving average is 3.25, while MEI Pharma’s (MEIP) share price is $6.6, making it a Buy.

MEI Pharma (MEIP) Pivot Points

Jul 26, 2025, 07:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.58
5.17
5.68
6.27
6.78
7.37
7.88
Fibonacci
5.17
5.59
5.85
6.27
6.69
6.95
7.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MEI Pharma (MEIP) Moving Averages

Jul 26, 2025, 07:56 AM
Period
Simple
Exponential
MA5
6.43Buy
6.11Buy
MA10
4.92Buy
5.27Buy
MA20
3.76Buy
4.28Buy
MA50
2.83Buy
3.25Buy
MA100
2.49Buy
2.84Buy
MA200
2.63Buy
2.81Buy
MEI Pharma’s (MEIP) 10-Day exponential moving average is 5.27, while MEI Pharma’s (MEIP) share price is $6.6, making it a Buy.
MEI Pharma’s (MEIP) 100-Day exponential moving average is 2.84, while MEI Pharma’s (MEIP) share price is $6.6, making it a Buy.
MEI Pharma’s (MEIP) stock price is $6.6 and MEI Pharma’s (MEIP) 50-day simple moving average is 2.83, creating a Buy signal.
MEI Pharma’s (MEIP) stock price is $6.6 and MEI Pharma’s (MEIP) 100-day simple moving average is 2.49, creating a Buy signal.
MEI Pharma’s (MEIP) stock price is $6.6 and MEI Pharma’s (MEIP) 200-day simple moving average is 2.63, creating a Buy signal.

MEI Pharma (MEIP) Technical Indicators

Jul 26, 2025, 07:56 AM
Name
Value
Implied Action
RSI (14)
81.51
Sell
STOCH (9,6)
61.53
Neutral
STOCHRSI (14)
62.68
Neutral
MACD (12,26)
1.07
Sell
ADX (14)
72.68
Sell
Williams %R
-37.50
Buy
CCI (14)
122.73
Sell
ATR (14)
0.78
-
Ultimate Oscillator
45.77
Neutral
ROC
146.27
Buy
MEI Pharma’s (MEIP) Relative Strength Index (RSI) is 81.51, creating a Sell signal.
MEI Pharma’s (MEIP) Trend Strength Indicator (ADX) is 72.68, creating a Sell signal.
MEI Pharma’s (MEIP) Commodity Channel Index (CCI) is 122.73, creating a Sell signal.
MEI Pharma’s (MEIP) Price Rate of Change (ROC) is 146.27, creating a Buy signal.

FAQ

Is MEIP a Buy, Hold, or Sell?
Based on MEIP’s technical indicators, MEIP is a Buy.
    What is MEIP’s RSI (14)?
    MEIP’s RSI (14) is 81.51, which suggests MEIP is a Sell.
      What is MEIP’s MACD?
      MEIP’s MACD is 1.07, which suggests MEIP is a Sell.
        What is MEIP’s 5-day moving average?
        MEIP’s 5-day moving average is 6.43, which suggests MEIP is a Buy.
          What is MEIP’s 20-day moving average?
          MEIP 20-day moving average is 3.76, which suggests MEIP is a Buy.
            What is MEIP’s 50-day moving average?
            MEIP’s 50-day moving average is 2.83, which suggests MEIP is a Buy.
              What is MEIP’s 200-day moving average?
              MEIP’s 200-day moving average is 2.63, which suggests MEIP is a Buy.
                What is MEIP’s Williams % R (14)?
                MEIP’s Williams % R (14) is -37.50, which suggests MEIP is a Buy.
                  What is MEIP’s CCI (14)?
                  MEIP’s CCI (14) is 122.73, which suggests MEIP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis